Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Big Pharma CEOs Descend On China: What’s The Likely Agenda?

Executive Summary

In a major show of force, four global pharma CEOs are heading to China to participate in high-level open and closed-door discussions that are expected to include a range of policy and regulatory reform topics. Tapping into China’s push to improve health and develop an innovation-driven economy may provide new openings for their voices to be heard.

Advertisement

Related Content

Now Is The Time! Rule Changes To Smooth China New Drug Approvals?
Now Is The Time! Rule Changes To Open Up China To Foreign New Drugs?
Foreign Drugs Welcome As China Reforms Progress: CFDA Commissioner
Spring Coming? EU Group Holds China To Fair Play Promises In Procurement
Chi-Med Roll Continues With Positive Fruquintinib Phase III Data
Sweeping China Policy Reforms Seen Bolstering Domestic Generics
Sanofi's Biosimilars Deal With JHL Confirms Growing Trend In China
Novartis Pursues ‘Invented In China’ Goal At New Shanghai Hub

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC098405

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel